SCHEMBL19923628

SCHEMBL19923628

CCN1C(=O)N([Si](C)(C)C)C(=O)C1(C)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.39
BACE2 Q9Y5Z0 2/20 0.39
LMNA P02545 3/20 0.39
GAA P10253 2/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
MPI P34949 1/20 0.39
KMT2A Q03164 1/20 0.39
MCL1 Q07820 1/20 0.39
HTR1A P08908 3/20 0.38
HTR6 P50406 3/20 0.38
ALDH1A1 P00352 3/20 0.36
TSHR P16473 2/20 0.35
CYP2C19 P33261 2/20 0.35
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923502 0.87 BACE1 (0.38) BACE1BACE2LMNAGAAHTT
SCHEMBL19923410 0.85 ALDH1A1 (0.38) BACE1BACE2LMNAGAAHTT
SCHEMBL19923470 0.85 BACE1 (0.38) BACE1BACE2LMNAGAAHTT
SCHEMBL19923637 0.85 ELANE (0.44) LMNAGAAHTR1AHTR6ALDH1A1
SCHEMBL19923716 0.83 BACE1 (0.40) BACE1BACE2LMNAGAAHTT
SCHEMBL19923565 0.81 MITF (0.41) BACE1BACE2LMNAGAAHTT
SCHEMBL19923474 0.80 BACE1 (0.45) BACE1BACE2LMNAGAAHTT
SCHEMBL19923728 0.80 PKM (0.40) BACE1BACE2LMNAGAAMCL1
SCHEMBL19923706 0.80 ALDH1A1 (0.39) BACE1BACE2LMNAGAAHTT
SCHEMBL19923594 0.77 ALDH1A1 (0.37) BACE1BACE2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN BACE1 4315/4885BACE2 4642/4885LMNA 336/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM BACE1 4432/4885BACE2 4717/4885LMNA 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.